Solaris Health Appoints Dr. Shawn H. Zimberg as National Director of Radiation Oncology Services

Appointment enhances access to expert specialty care for Solaris patients

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Solaris Health Holdings, the nation’s leading provider of independent urological services, announced today that Shawn H. Zimberg, MD has been named National Director of Radiation Oncology Services.

Dr. Zimberg brings over 25 years of clinical expertise and management experience in radiation oncology to this new position at Solaris.

Dr. Zimberg is a leading authority in the development and management of radiation oncology practices as well as the optimization of financial and clinical efficiencies in multi-site and regional oncology facilities. Dr. Zimberg was a founding partner of, and is the Medical Director of Advanced Radiation Centers of New York (ARC), and serves on the board of the Association of Free-standing Radiation Oncology Centers (AFROC). Under his leadership ARC has become the largest freestanding radiation oncology practice in the Metro New York Tri-State Region, and has developed an infrastructure and service line that provides physics, dosimetry and IT support to oncology practices across the nation. Over his career, Dr. Zimberg has been at the forefront of deploying sophisticated radiation oncology technologies for brain, lung, head and neck, and prostate cancer treatments.

“The appointment of Dr. Zimberg is the next step in Solaris’ commitment to enhancing access to specialty and oncology-based healthcare,” said Eric Mason, MD, MBA, Solaris’ CEO. “Selecting a physician with Dr. Zimberg’s vast experience will help us standardize care and optimize patient outcomes throughout Solaris affiliated practices across the country, and will provide increased opportunities for growth in our oncology-related ancillary services,” he said.

“I’m honored by the opportunity to join the Solaris Health management team,” Dr. Zimberg said. “Radiation is a critical weapon in the arsenal against prostate and other urologic cancers, and I look forward to contributing to Solaris’ development as a national radiation oncology platform predicated on innovation and clinical excellence.”

New York-based Lee Equity Partners is a financial partner in Solaris. Learn more at www.solarishealthpartners.com.

About Solaris Health

Solaris Health is a leading national healthcare platform committed to enhancing access to specialty healthcare and continually improving patient outcomes. Empowering community providers allows us to make sure that every decision we make puts patient care at the forefront. We are growing to meet the changing needs of the healthcare providers, and to develop innovative ways to better deliver value and state-of-the-art care to our patients. Solaris Health is proud to be among the most innovative medical organizations in the United States.

Visit www.solarishealthpartners.com.

About Lee Equity Partners

Lee Equity Partners is a New York-based private equity firm that partners with successful management teams to build companies with strong growth potential. Lee Equity targets equity investments of $50 million to $150 million in middle-market control buyouts and growth capital financings in companies with enterprise values of $100 million to $500 million that are located primarily in the United States. The firm invests in a range of industries where the team has deep relationships developed over decades, including business services, financial services, and healthcare services.

Visit www.LeeEquity.com.